{"title":"A rare case of pyomyoma following hysterotomy in a premenopausal woman with leiomyoma.","authors":"Sunayna Lashkari, Avantika Gupta, Ayushi Sethi, Sahithi Kosgi","doi":"10.4274/jtgga.galenos.2026.2025-8-5","DOIUrl":"https://doi.org/10.4274/jtgga.galenos.2026.2025-8-5","url":null,"abstract":"","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146125412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This systematic review and meta-analysis evaluated epithelial ovarian cancer (EOC) incidence rates associated with salpingectomy, with an exploratory assessment of temporal trends following guideline-driven increases in opportunistic salpingectomy. A literature search was conducted across PubMed, Web of Science, Cochrane, and Scopus, targeting cohort studies published between January 2015 and September 2023. Eligible studies were cohort studies reporting EOC incidence in women undergoing salpingectomy (opportunistic or risk-reducing) compared to controls without salpingectomy, with sufficient sample sizes (>100 salpingectomy cases) and homogeneous populations. The Newcastle-Ottawa Scale (NOS) was used to assess methodological quality. A meta-analysis calculated the risk ratio (RR) of EOC incidence, with subgroup analysis exploring temporal trends, using a random-effects model. Five cohort studies, involving 5,819,102 women with 31,586 EOC cases, were included, all with low risk-of-bias (NOS scores ≥6). Salpingectomy was associated with a 77.7% reduction in EOC incidence compared to control patients [RR =0.223, 95% confidence interval: (0.182, 0.274), p<0.001; I²=0]%. The 2022-2023 period should be interpreted as a recent evidence window rather than a formally powered comparative period owing to the small number of studies available. These findings confirm that salpingectomy, particularly opportunistic procedures, substantially reduces EOC incidence. Clinicians should consider offering salpingectomy to average-risk women during gynecologic surgeries, with informed consent. Further research with longer follow-up of contemporary cohorts is needed.
本系统综述和荟萃分析评估了与输卵管切除术相关的上皮性卵巢癌(EOC)发病率,并对指南驱动的机会性输卵管切除术增加的时间趋势进行了探索性评估。在PubMed、Web of Science、Cochrane和Scopus上进行了文献检索,目标是2015年1月至2023年9月之间发表的队列研究。符合条件的研究是报告接受输卵管切除术(机会性或降低风险)的女性与未接受输卵管切除术的对照组相比EOC发病率的队列研究,具有足够的样本量(100例输卵管切除术病例)和同质人群。采用纽卡斯尔-渥太华量表(NOS)评价方法学质量。荟萃分析计算了EOC发病率的风险比(RR),并使用随机效应模型进行亚组分析,探索时间趋势。纳入了5项队列研究,涉及5,819,102名女性,31,586例EOC病例,均为低偏倚风险(NOS评分≥6)。与对照组相比,输卵管切除术与EOC发病率降低77.7%相关[RR =0.223, 95%可信区间:(0.182,0.274),p
{"title":"Meta-analysis of changes in epithelial ovarian cancer incidence rates associated with salpingectomy: A comparison of 2022-2023 and earlier periods.","authors":"Greg Marchand, Daniela Gonzalez Herrera, Brooke Hamilton, McKenna Robinson, Emily Kline, Sarah Mera, Michelle Koshaba, Greenley Jephson, Nidhi Pulicherla, Ali Azadi","doi":"10.4274/jtgga.galenos.2025.2025-5-7","DOIUrl":"https://doi.org/10.4274/jtgga.galenos.2025.2025-5-7","url":null,"abstract":"<p><p>This systematic review and meta-analysis evaluated epithelial ovarian cancer (EOC) incidence rates associated with salpingectomy, with an exploratory assessment of temporal trends following guideline-driven increases in opportunistic salpingectomy. A literature search was conducted across PubMed, Web of Science, Cochrane, and Scopus, targeting cohort studies published between January 2015 and September 2023. Eligible studies were cohort studies reporting EOC incidence in women undergoing salpingectomy (opportunistic or risk-reducing) compared to controls without salpingectomy, with sufficient sample sizes (>100 salpingectomy cases) and homogeneous populations. The Newcastle-Ottawa Scale (NOS) was used to assess methodological quality. A meta-analysis calculated the risk ratio (RR) of EOC incidence, with subgroup analysis exploring temporal trends, using a random-effects model. Five cohort studies, involving 5,819,102 women with 31,586 EOC cases, were included, all with low risk-of-bias (NOS scores ≥6). Salpingectomy was associated with a 77.7% reduction in EOC incidence compared to control patients [RR =0.223, 95% confidence interval: (0.182, 0.274), p<0.001; I²=0]%. The 2022-2023 period should be interpreted as a recent evidence window rather than a formally powered comparative period owing to the small number of studies available. These findings confirm that salpingectomy, particularly opportunistic procedures, substantially reduces EOC incidence. Clinicians should consider offering salpingectomy to average-risk women during gynecologic surgeries, with informed consent. Further research with longer follow-up of contemporary cohorts is needed.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-04DOI: 10.4274/jtgga.galenos.2026.2025-9-22
Belgin Savran Üçok, Türkan Dikici Aktaş, Emel Özalp, Can Ozan Ulusoy, Özgür Volkan Akbulut, Aziz Kından, Fahri Burçin Fıratlıgil
Objective: To compare hormonal and metabolic characteristics across Rotterdam polycystic ovary syndrome (PCOS) phenotypes (A-D) and identify key predictors of hyperandrogenism.
Material and methods: In this retrospective cohort study, women with PCOS were classified into four Rotterdam phenotypes. Hormonal and metabolic parameters were assessed in the early follicular phase, and composite indices including HOMA-IR, QUICKI, TG/HDL, and free androgen index (FAI) were calculated. Logistic regression and receiver operating characteristic analysis were used to evaluate predictors of hirsutism.
Results: The study included 226 women, with respective phenotype subgroups of: A n=85; B n=29; C n=43; and D n=69. Phenotype A showed the most pronounced hyperandrogenic and metabolic alterations, whereas phenotype D displayed the mildest profile with lower androgen levels and hirsutism scores. Significant differences in insulin resistance and lipid-related indices were observed across phenotypes. FAI was the strongest predictor of hirsutism (area under the curve =0.861), followed by total testosterone and dehydroepiandrosterone sulfate, while sex-hormone binding globulin was inversely associated.
Conclusion: PCOS phenotypes demonstrate distinct hormonal and metabolic patterns. Phenotype A represents the most metabolically and androgenically severe subgroup, whereas phenotype D is comparatively mild. FAI emerges as the most informative marker for hirsutism, supporting a phenotype-oriented approach to clinical assessment and follow-up in PCOS.
目的:比较鹿特丹多囊卵巢综合征(PCOS)表型(A-D)的激素和代谢特征,并确定高雄激素血症的关键预测因素。材料和方法:在这项回顾性队列研究中,多囊卵巢综合征女性被分为四种鹿特丹表型。在卵泡早期评估激素和代谢参数,计算HOMA-IR、QUICKI、TG/HDL和游离雄激素指数(FAI)等综合指数。采用Logistic回归和受试者工作特征分析评估多毛症的预测因素。结果:该研究纳入226名女性,其表型亚组分别为:A n=85;B n = 29;C n = 43;n=69。表现型A表现出最明显的高雄激素和代谢改变,而表现型D表现出最轻微的特征,雄激素水平较低,多毛症评分较低。胰岛素抵抗和脂质相关指标在不同表型中存在显著差异。FAI是多毛症的最强预测因子(曲线下面积=0.861),其次是总睾酮和硫酸脱氢表雄酮,而性激素结合球蛋白呈负相关。结论:多囊卵巢综合征表型表现出不同的激素和代谢模式。表型A代表代谢和雄激素最严重的亚群,而表型D相对较轻。FAI是多毛症最具信息性的标志物,支持以表型为导向的多囊卵巢综合征临床评估和随访方法。
{"title":"Comparative analysis of hormonal and metabolic indices in phenotypic subgroups of polycystic ovary syndrome.","authors":"Belgin Savran Üçok, Türkan Dikici Aktaş, Emel Özalp, Can Ozan Ulusoy, Özgür Volkan Akbulut, Aziz Kından, Fahri Burçin Fıratlıgil","doi":"10.4274/jtgga.galenos.2026.2025-9-22","DOIUrl":"https://doi.org/10.4274/jtgga.galenos.2026.2025-9-22","url":null,"abstract":"<p><strong>Objective: </strong>To compare hormonal and metabolic characteristics across Rotterdam polycystic ovary syndrome (PCOS) phenotypes (A-D) and identify key predictors of hyperandrogenism.</p><p><strong>Material and methods: </strong>In this retrospective cohort study, women with PCOS were classified into four Rotterdam phenotypes. Hormonal and metabolic parameters were assessed in the early follicular phase, and composite indices including HOMA-IR, QUICKI, TG/HDL, and free androgen index (FAI) were calculated. Logistic regression and receiver operating characteristic analysis were used to evaluate predictors of hirsutism.</p><p><strong>Results: </strong>The study included 226 women, with respective phenotype subgroups of: A n=85; B n=29; C n=43; and D n=69. Phenotype A showed the most pronounced hyperandrogenic and metabolic alterations, whereas phenotype D displayed the mildest profile with lower androgen levels and hirsutism scores. Significant differences in insulin resistance and lipid-related indices were observed across phenotypes. FAI was the strongest predictor of hirsutism (area under the curve =0.861), followed by total testosterone and dehydroepiandrosterone sulfate, while sex-hormone binding globulin was inversely associated.</p><p><strong>Conclusion: </strong>PCOS phenotypes demonstrate distinct hormonal and metabolic patterns. Phenotype A represents the most metabolically and androgenically severe subgroup, whereas phenotype D is comparatively mild. FAI emerges as the most informative marker for hirsutism, supporting a phenotype-oriented approach to clinical assessment and follow-up in PCOS.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-28DOI: 10.4274/jtgga.galenos.2025.2025-9-9
Yeliz Kaya, Tuğba Tahta, Yunus Aydın, Coşkun Kaya
Objective: To investigate the relationship between belief in sexual myths and the presence of vaginismus, and to evaluate the influence of sociodemographic and cultural factors on sexual myth endorsement among Turkish women.
Material and methods: This case-control study included women diagnosed with vaginismus and an equal number of age-matched women without sexual dysfunction. Participants completed a sociodemographic questionnaire and the sexual myths (SMS). Comparative analyses were conducted to assess differences in total and subscale scores between groups, and multiple regression analysis was performed to evaluate the predictive role of sociodemographic variables on belief in sexual myths.
Results: Women with vaginismus (n=40) had significantly higher total scores on the SMS compared to the control group (n=40; p<0.001). Subscale analyses revealed that myths related to sexuality, gender roles, and sexual morality were more strongly endorsed by women with vaginismus. Multiple regression analysis showed that lower education level, conservative family background, and rural upbringing were significant predictors of stronger belief in sexual myths (p<0.05).
Conclusion: The findings suggest that belief in sexual myths is more prevalent among women with vaginismus and is influenced by key sociodemographic and cultural factors. Addressing these beliefs through culturally sensitive education and psychosexual interventions may enhance the effectiveness of vaginismus treatment.
{"title":"Belief in sexual myths and sociocultural factors associated with vaginismus: a case-control study in Turkish women.","authors":"Yeliz Kaya, Tuğba Tahta, Yunus Aydın, Coşkun Kaya","doi":"10.4274/jtgga.galenos.2025.2025-9-9","DOIUrl":"https://doi.org/10.4274/jtgga.galenos.2025.2025-9-9","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the relationship between belief in sexual myths and the presence of vaginismus, and to evaluate the influence of sociodemographic and cultural factors on sexual myth endorsement among Turkish women.</p><p><strong>Material and methods: </strong>This case-control study included women diagnosed with vaginismus and an equal number of age-matched women without sexual dysfunction. Participants completed a sociodemographic questionnaire and the sexual myths (SMS). Comparative analyses were conducted to assess differences in total and subscale scores between groups, and multiple regression analysis was performed to evaluate the predictive role of sociodemographic variables on belief in sexual myths.</p><p><strong>Results: </strong>Women with vaginismus (n=40) had significantly higher total scores on the SMS compared to the control group (n=40; p<0.001). Subscale analyses revealed that myths related to sexuality, gender roles, and sexual morality were more strongly endorsed by women with vaginismus. Multiple regression analysis showed that lower education level, conservative family background, and rural upbringing were significant predictors of stronger belief in sexual myths (p<0.05).</p><p><strong>Conclusion: </strong>The findings suggest that belief in sexual myths is more prevalent among women with vaginismus and is influenced by key sociodemographic and cultural factors. Addressing these beliefs through culturally sensitive education and psychosexual interventions may enhance the effectiveness of vaginismus treatment.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146064355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-22DOI: 10.4274/jtgga.galenos.2025.2025-10-5
Mehmet Tunç, Göğşen Önalan, Mehmet Coşkun, Asuman Nihan Haberal, Ülkü Esra Kuşçu
We present a rare Müllerian anomaly known as "accessory cavitated uterine mass (ACUM)," which causes severe, refractory dysmenorrhea, and review the literature. A 17-year-old patient experienced severe, cyclic left-sided pelvic pain, correlating with menstruation. Magnetic resonance imaging (MRI) revealed a cystic lesion surrounded by myometrial tissue. Medical treatment with oral contraceptives was unsuccessful. Laparoscopic excision of the mass was performed, and histopathology confirmed the diagnosis of ACUM. At six months postoperatively, she remained asymptomatic, and follow-up MRI showed a normal-appearing uterus. ACUM is a rare Müllerian anomaly that is challenging to diagnose preoperatively, even with advanced imaging. Surgical excision remains the definitive treatment. This case highlights the importance of clinicians considering Müllerian anomalies in adolescents presenting with severe dysmenorrhea.
{"title":"Accessory cavitated uterine mass: A rare cause of severe dysmenorrhea.","authors":"Mehmet Tunç, Göğşen Önalan, Mehmet Coşkun, Asuman Nihan Haberal, Ülkü Esra Kuşçu","doi":"10.4274/jtgga.galenos.2025.2025-10-5","DOIUrl":"https://doi.org/10.4274/jtgga.galenos.2025.2025-10-5","url":null,"abstract":"<p><p>We present a rare Müllerian anomaly known as \"accessory cavitated uterine mass (ACUM),\" which causes severe, refractory dysmenorrhea, and review the literature. A 17-year-old patient experienced severe, cyclic left-sided pelvic pain, correlating with menstruation. Magnetic resonance imaging (MRI) revealed a cystic lesion surrounded by myometrial tissue. Medical treatment with oral contraceptives was unsuccessful. Laparoscopic excision of the mass was performed, and histopathology confirmed the diagnosis of ACUM. At six months postoperatively, she remained asymptomatic, and follow-up MRI showed a normal-appearing uterus. ACUM is a rare Müllerian anomaly that is challenging to diagnose preoperatively, even with advanced imaging. Surgical excision remains the definitive treatment. This case highlights the importance of clinicians considering Müllerian anomalies in adolescents presenting with severe dysmenorrhea.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146018911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12DOI: 10.4274/jtgga.galenos.2025.2025-5-12
Mete Işıkoğlu, Ayşenur Avcı, Ayşe Kendirci Çeviren, Batu Aydınuraz
Objective: Contrary to international guidelines, intracytoplasmic injection (ICSI) has increasingly been applied to a widening range of indications. The aim of this study is to present our experience with conventional in vitro fertilization (C-IVF) in women in their forties and to contribute to the ongoing debate on whether advanced maternal age should be considered an indication for preferring ICSI.
Material and methods: We analyzed cases of non-male factor infertility in women aged ≥40 years. The primary outcome measures were fertilization rate, implantation rate, live birth rate, and miscarriage rate.
Results: The cohort included 204 patients with a mean age of 42.30±1.97 years, a mean antral follicle count of 4.65±2.60, body mass index of 25.80±4.54 kg/m2 and a mean duration of infertility of 4.12±4.03 years. The mean duration of stimulation was 8.73±2.22 days, with a mean gonadotropin dose of 261.82±65.25 IU. The fertilisation rate was 74.69%. A mean of 1.77±0.60 embryos were transferred resulting in an implantation rate, clinical pregnancy rate and live birth rate of 10.44%, 18.62%, 12.25% respectively.
Conclusion: Fertilisation, implantation, live birth and miscarriage rates after C-IVF are satisfactory for women ≥40 years of age. Given its lower cost, ease of application and comparable clinical outcomes, C-IVF should be considered the preferred method of fertilisation in advanced-age patients.
{"title":"Conventional IVF at the age of fourties.","authors":"Mete Işıkoğlu, Ayşenur Avcı, Ayşe Kendirci Çeviren, Batu Aydınuraz","doi":"10.4274/jtgga.galenos.2025.2025-5-12","DOIUrl":"https://doi.org/10.4274/jtgga.galenos.2025.2025-5-12","url":null,"abstract":"<p><strong>Objective: </strong>Contrary to international guidelines, intracytoplasmic injection (ICSI) has increasingly been applied to a widening range of indications. The aim of this study is to present our experience with conventional in vitro fertilization (C-IVF) in women in their forties and to contribute to the ongoing debate on whether advanced maternal age should be considered an indication for preferring ICSI.</p><p><strong>Material and methods: </strong>We analyzed cases of non-male factor infertility in women aged ≥40 years. The primary outcome measures were fertilization rate, implantation rate, live birth rate, and miscarriage rate.</p><p><strong>Results: </strong>The cohort included 204 patients with a mean age of 42.30±1.97 years, a mean antral follicle count of 4.65±2.60, body mass index of 25.80±4.54 kg/m<sup>2</sup> and a mean duration of infertility of 4.12±4.03 years. The mean duration of stimulation was 8.73±2.22 days, with a mean gonadotropin dose of 261.82±65.25 IU. The fertilisation rate was 74.69%. A mean of 1.77±0.60 embryos were transferred resulting in an implantation rate, clinical pregnancy rate and live birth rate of 10.44%, 18.62%, 12.25% respectively.</p><p><strong>Conclusion: </strong>Fertilisation, implantation, live birth and miscarriage rates after C-IVF are satisfactory for women ≥40 years of age. Given its lower cost, ease of application and comparable clinical outcomes, C-IVF should be considered the preferred method of fertilisation in advanced-age patients.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145952486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12DOI: 10.4274/jtgga.galenos.2025.2025-10-17
Aparna Setty, Mishu Mangla, Kona Kiran Kumar Reddy, Madhavan Velladurai
{"title":"Ovotesticular disorder of sex development presenting in adolescence with amenorrhea and clitoromegaly-what is your diagnosis?","authors":"Aparna Setty, Mishu Mangla, Kona Kiran Kumar Reddy, Madhavan Velladurai","doi":"10.4274/jtgga.galenos.2025.2025-10-17","DOIUrl":"https://doi.org/10.4274/jtgga.galenos.2025.2025-10-17","url":null,"abstract":"","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145952452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-29DOI: 10.4274/jtgga.galenos.2025.2024-9-6
Talat Umut Kutlu Dilek, Eren Kaya, Elif Aygün, Özlem Pata
Objective: To share our experience of ultrasonographic evaluation of fetal anatomy in the first trimester and pregnancy follow-up in a tertiary center.
Material and methods: This retrospective study was conducted in the Acıbadem University Atakent Hospital and Acıbadem University Bakırköy Hospital Prenatal Diagnosis Units between April 2015 and December 2019. The study group included pregnant women referred for first-trimester aneuploidy screening and anomaly survey.
Results: The mean maternal age was 31.28±4.43 years and ranged from 20-49 years. The median gestational week at which first-trimester evaluation was made was 12.4 weeks. Of 3254 cases, 55 (1.69%) had pathologic ultrasound findings in the first-trimester anomaly scan, including increased nuchal translucency (NT) value over 95th percentile in 34 fetuses (52.3%) with structural anomaly. Median (range) crown-rump length was 58.69 (45-83) mm, and the median NT value was 3,5 (1.5-12) mm for fetuses with abnormal sonographic findings. The total detection rate for sonographic anomalies in the first-trimester scan was 60.43%. Of note, 27.3% of fetuses with detected anomalies had multiple congenital anomalies. Twenty-four new cases were diagnosed in the second trimester, and 11 new cases were detected in the last trimester from the same cohort.
Conclusion: Screening between 11-14 weeks of pregnancy may be an opportunity to evaluate maternal health and detect severe fetal anomalies. The family should be counseled about structural anomalies that may be detected later, especially in the second and third trimesters, the limitations of the technique, and the ongoing progress of fetal development.
{"title":"Is first trimester screening an opportunity for early diagnosis of structural anomalies?: A retrospective cohort study.","authors":"Talat Umut Kutlu Dilek, Eren Kaya, Elif Aygün, Özlem Pata","doi":"10.4274/jtgga.galenos.2025.2024-9-6","DOIUrl":"https://doi.org/10.4274/jtgga.galenos.2025.2024-9-6","url":null,"abstract":"<p><strong>Objective: </strong>To share our experience of ultrasonographic evaluation of fetal anatomy in the first trimester and pregnancy follow-up in a tertiary center.</p><p><strong>Material and methods: </strong>This retrospective study was conducted in the Acıbadem University Atakent Hospital and Acıbadem University Bakırköy Hospital Prenatal Diagnosis Units between April 2015 and December 2019. The study group included pregnant women referred for first-trimester aneuploidy screening and anomaly survey.</p><p><strong>Results: </strong>The mean maternal age was 31.28±4.43 years and ranged from 20-49 years. The median gestational week at which first-trimester evaluation was made was 12.4 weeks. Of 3254 cases, 55 (1.69%) had pathologic ultrasound findings in the first-trimester anomaly scan, including increased nuchal translucency (NT) value over 95th percentile in 34 fetuses (52.3%) with structural anomaly. Median (range) crown-rump length was 58.69 (45-83) mm, and the median NT value was 3,5 (1.5-12) mm for fetuses with abnormal sonographic findings. The total detection rate for sonographic anomalies in the first-trimester scan was 60.43%. Of note, 27.3% of fetuses with detected anomalies had multiple congenital anomalies. Twenty-four new cases were diagnosed in the second trimester, and 11 new cases were detected in the last trimester from the same cohort.</p><p><strong>Conclusion: </strong>Screening between 11-14 weeks of pregnancy may be an opportunity to evaluate maternal health and detect severe fetal anomalies. The family should be counseled about structural anomalies that may be detected later, especially in the second and third trimesters, the limitations of the technique, and the ongoing progress of fetal development.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145850379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Autonomic nerves regulate the innervation and function of the bladder, uterus, and rectum via their terminal branches. This section emphasizes the superior hypogastric plexus, hypogastric nerve, pelvic splanchnic nerves, inferior hypogastric plexus, and its terminal branches, namely the vesical, rectal, and uterine nerves. Somatic nerves traverse the pelvis, providing motor and/or sensory innervation to the pelvic floor and lower limbs. It is important to recognize the obturator nerve, genitofemoral nerve, lateral femoral cutaneous nerve, lumbosacral trunk, and femoral nerve.
{"title":"Neuropelviology in minimally invasive surgery: a surgical anatomy-based demonstration.","authors":"İlker Selçuk, Tufan Arslanca, Eda Kayalı, Derya Leblebici, Koray Görkem Saçıntı, Hakan Raşit Yalçın","doi":"10.4274/jtgga.galenos.2025.2025-7-10","DOIUrl":"10.4274/jtgga.galenos.2025.2025-7-10","url":null,"abstract":"<p><p>Autonomic nerves regulate the innervation and function of the bladder, uterus, and rectum via their terminal branches. This section emphasizes the superior hypogastric plexus, hypogastric nerve, pelvic splanchnic nerves, inferior hypogastric plexus, and its terminal branches, namely the vesical, rectal, and uterine nerves. Somatic nerves traverse the pelvis, providing motor and/or sensory innervation to the pelvic floor and lower limbs. It is important to recognize the obturator nerve, genitofemoral nerve, lateral femoral cutaneous nerve, lumbosacral trunk, and femoral nerve.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":"319-320"},"PeriodicalIF":1.4,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12676985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145286237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-03Epub Date: 2025-09-19DOI: 10.4274/jtgga.galenos.2025.2025-3-10
Tuğba Akçaoğlu, Yağmur Soykan, Neslihan Bayramoğlu Tepe, Ozan Doğan
Objective: Human papillomavirus (HPV) positivity is associated with cervical, oropharyngeal, and anal cancers. There is insufficient published evidence regarding the effectiveness of obtaining oropharyngeal and anal swabs from patients with cervical HPV positivity to detect potential pathologies. Our aim was to analyze the feasibility of this potential screening protocol in a pilot group.
Material and methods: In this cross-sectional exploratory analysis, women diagnosed with cervical intraepithelial neoplasia (CIN) grades 1, 2, or 3 were recruited. In order to evaluate HPV infection beyond the cervix, oropharyngeal and anal swab samples from HPV-positive women presenting to the obstetrics and gynecology clinic with histopathologically confirmed CIN were collected.
Results: A total of 30 women who provided informed consent were included in this pilot study. HPV 16 was the predominant cervical HPV type across all CIN grades (46.7% of cases), but HPV genotype did not significantly correlate with the severity of CIN lesions (p=0.786). No statistically significant association was found between cervical and anal HPV infections (p=0.427). Oral HPV positivity was rare (6.7%) and similarly showed no significant correlation with cervical HPV infection (p=0.499).
Conclusion: These findings provide preliminary data on the effectiveness of multi-site HPV screening in this population. Future larger-scale studies are needed to determine whether detecting extra-cervical HPV in women with cervical HPV positivity will influence clinical management decisions.
{"title":"Multi-site HPV infection in women with cervical intraepithelial neoplasia: an exploratory analysis.","authors":"Tuğba Akçaoğlu, Yağmur Soykan, Neslihan Bayramoğlu Tepe, Ozan Doğan","doi":"10.4274/jtgga.galenos.2025.2025-3-10","DOIUrl":"10.4274/jtgga.galenos.2025.2025-3-10","url":null,"abstract":"<p><strong>Objective: </strong>Human papillomavirus (HPV) positivity is associated with cervical, oropharyngeal, and anal cancers. There is insufficient published evidence regarding the effectiveness of obtaining oropharyngeal and anal swabs from patients with cervical HPV positivity to detect potential pathologies. Our aim was to analyze the feasibility of this potential screening protocol in a pilot group.</p><p><strong>Material and methods: </strong>In this cross-sectional exploratory analysis, women diagnosed with cervical intraepithelial neoplasia (CIN) grades 1, 2, or 3 were recruited. In order to evaluate HPV infection beyond the cervix, oropharyngeal and anal swab samples from HPV-positive women presenting to the obstetrics and gynecology clinic with histopathologically confirmed CIN were collected.</p><p><strong>Results: </strong>A total of 30 women who provided informed consent were included in this pilot study. HPV 16 was the predominant cervical HPV type across all CIN grades (46.7% of cases), but HPV genotype did not significantly correlate with the severity of CIN lesions (p=0.786). No statistically significant association was found between cervical and anal HPV infections (p=0.427). Oral HPV positivity was rare (6.7%) and similarly showed no significant correlation with cervical HPV infection (p=0.499).</p><p><strong>Conclusion: </strong>These findings provide preliminary data on the effectiveness of multi-site HPV screening in this population. Future larger-scale studies are needed to determine whether detecting extra-cervical HPV in women with cervical HPV positivity will influence clinical management decisions.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":"289-296"},"PeriodicalIF":1.4,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12676993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145081158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}